Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

5th NASH Summit 2021

Evvnt Promotion / evvnt
-
29.11.2021 - 02.12.2021  Online
10:00 am - 3:30 pm
 
Temi della conferenza
Masterfully combining the hottest insights on NASH from 65+ strong speaker faculty, including 45+ brand new speakers from the FDA, EMA, Takeda, Eli Lilly, Gilead, Pfizer, AstraZeneca, Ionis, Novo Nordisk and more, the 5th NASH Summit is your best opportunity to unite with fellow NASH drug developers to gain critical updates on the trailblazing research you need to meaningfully reassess your therapeutic approach and optimize your pipeline strategy for the future.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/848618-3?pid=4832

Speakers: Christopher Jones Director of Biology Terns Pharmaceuticals, Elias Papatheodoru Chief Executive Officer Genkyotex and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/848618-2?pid=4832
Ms. Kaltrina Kastrati
 
Categorie
Medicina General, Ricerca clinica
Lingua
Inglese
Quote del Congresso
USD 2099.00 - USD 3495.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Swiss Tropical and Public Health InstituteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinnewTreeOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichisches Rotes KreuzCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrzte der WeltHilfswerk Austria